In the BioHarmony Drug Report Database
Arformoterol
Brovana (arformoterol) is a small molecule pharmaceutical. Arformoterol was first approved as Brovana on 2006-10-06. It is used to treat bronchial spasm, chronic bronchitis, and pulmonary emphysema in the USA. The pharmaceutical is active against beta-2 adrenergic receptor. In addition, it is known to target beta-1 adrenergic receptor. Brovana’s patents are valid until 2021-11-09 (FDA).
Trade Name
|
Brovana |
|---|---|
Common Name
|
arformoterol |
ChEMBL ID
|
CHEMBL1363 |
Indication
|
bronchial spasm, chronic bronchitis, pulmonary emphysema |
Drug Class
|
Bronchodilators (phenethylamine derivatives) |
Image (chem structure or protein)